Prednisolone 5 mg 40 tablets

$20.00

Produced in Ukraine

Free shipping

Description

Pharmacotherapeutic group: Hormone preparations for systemic use. Simple preparations of corticosteroids for systemic use. Glucocorticoids. ATX code Н02А В06.
Composition:
active substance: prednisolone;
1 tablet contains prednisolone 5 mg excipients: lactose, potato starch, calcium stearate.
Indications:
Rheumatic fever, rheumatic carditis, chorea minor. Systemic connective tissue diseases (systemic lupus erythematosus, scleroderma, periarteritis nodosa, dermatomyositis). Multiple sclerosis. Acute and chronic inflammatory diseases of the joints (rheumatoid arthritis, juvenile arthritis, ankylosing spondyloarthritis, gouty and psoriatic arthritis, polyarthritis, humeral periarthritis, osteoarthritis (including post-traumatic), Still’s syndrome in adults, bursitis, nonspecific tondylosis) … Bronchial asthma, status asthmaticus. Interstitial lung diseases (acute alveolitis, pulmonary fibrosis, sarcoidosis of II-III degree), lung cancer (in combination with cytostatics), beryllium disease, aspiration pneumonia (in combination with specific therapy), Leffler’s eosinophilic pneumonia, tuberculosis (pulmonary tuberculosis, tuberculous meningitis) – in combination with specific therapy. Primary and secondary adrenal insufficiency (including conditions after removal of the adrenal glands), congenital adrenal hyperplasia, adrenogenital syndrome, subacute thyroiditis. Acute and chronic allergic diseases (drug and food allergies, serum sickness, hay fever, atopic dermatitis, contact dermatitis involving a large body surface, urticaria, allergic rhinitis, Quincke’s edema, Stevens-Johnson syndrome, toxicoderma). Hepatitis. Hypoglycemic conditions. Autoimmune diseases (acute glomerulonephritis). Nephrotic syndrome. Inflammatory diseases of the gastrointestinal tract (ulcerative colitis, Crohn’s disease, local enteritis). Diseases of the blood and hematopoietic organs (agranulocytosis, panmyelopathy, myeloma, acute lymphocytic and myeloid leukemia, lymphogranulomatosis, thrombocytopenic purpura, secondary thrombocytopenia in adults, autoimmune hemolytic anemia, erythroblastroid anemia), congenital erythroblastic anemia. Autoimmune and other skin diseases (eczema, seborrheic dermatitis, psoriasis, Lyell’s syndrome, bullous herpetiformis dermatitis, pemphigus, exfoliative dermatitis). Postoperative, post-radiation, post-traumatic cerebral edema, with a brain tumor (use after parenteral glucocorticosteroids). Diseases of the eyes, incl. allergic and autoimmune (sympathetic ophthalmia, allergic forms of conjunctivitis, allergic corneal ulcer, non-suppurative keratitis, iridocyclitis, iritis, severe slow anterior and posterior uveitis, choroid, optic neuritis). Prevention of graft rejection reactions. Hypercalcemia associated with cancer. For the prevention and elimination of nausea, vomiting during cytostatic therapy.
Contraindications:
Hypersensitivity to drug components. Parasitic and infectious diseases of viral, fungal or bacterial etiology, which exist now or recently transferred: herpes simplex, herpes zoster (viremic phase), chickenpox, measles; amoebiasis, strongyloidosis (established or suspected); systemic mycosis, active or latent tuberculosis. Post-vaccination period (duration 10 weeks 8 weeks before and 2 weeks after vaccination), lymphadenitis after BCG vaccination. Immunodeficiency conditions caused by HIV infection. Diseases of the digestive tract: gastric ulcer and duodenal ulcer, esophagitis, gastritis, acute or latent peptic ulcer, newly created intestinal anastamosis, ulcerative colitis with the threat of perforation or abscess formation, diverticulitis. Diseases of the cardiovascular system: recent myocardial infarction, decompensated chronic heart failure, arterial hypertension, a tendency to thromboembolic disease. Diseases of the endocrine system: diabetes mellitus and impaired carbohydrate tolerance, thyrotoxicosis, hypothyroidism, Itsenko-Cushing’s disease. Severe chronic renal and / or hepatic failure, nephrourolithiasis. Hypoalbuminemia. Systemic osteoporosis. Myasthenia gravis. Acute psychosis. Obesity (III-IV centuries). Poliomyelitis (except for the form of bulbar encephalitis). Open and glaucoma.
Method of administration and dosage:
The dosage is set individually. When prescribing, the circadian rhythm of glucocorticoid secretion should be taken into account: most of the dose (2/3) or the entire dose must be taken in the morning, at about 8 am, and 1/3 in the evening. Adults. In acute conditions and as substitution therapy, the prednisolone is prescribed at a dose of 20-30 mg per day with a gradual transition to a maintenance dose of 5-10 mg. If necessary, the initial dose may be 15-100 mg / day, and the maintenance dose is 5-15 mg / day. Children. The initial dose for children is 1-2 mg / kg / day and is divided into 4-6 doses, and the maintenance dose is 300-600 μg / kg / day. Prednisolone is taken orally without chewing, with a small amount of liquid. Treatment is stopped slowly, gradually reducing the dose.

Shelf life:

3 years.

Storage conditions:

Keep out of the reach of children in its original packaging at a temperature not exceeding 25 ° C.